期刊文献+

反义hTERT/PTEN联合基因治疗恶性胶质瘤的体内外研究 被引量:6

Study on combined gene therapy for malignant gliomas transfected with antisense hTERT/PTEN in vitro and in vivo
原文传递
导出
摘要 目的探讨腺病毒介导的反义hTERT和野生型PTEN联合基因转染对恶性胶质瘤细胞生长的影响。方法用细菌内高效同源重组系统构建的含有hTERT反义序列及野生型PTEN的腺病毒在体内外单独或联合转染恶性胶质瘤细胞系U251,检测肿瘤细胞生长情况、端粒酶活性、蛋白表达、细胞周期变化等。结果在体外试验中单独或联合转染都能明显抑制肿瘤细胞的生长,以联合转染效果最明显,转染后第6天联合转染组的细胞生存率为37.6%,端粒酶活性水平和hTERT蛋白表达水平明显下降,分别为28·8TPG、0.2106,PTEN蛋白表达水平上升为0.9630;在体内试验中肿瘤生长也明显减慢。结论腺病毒介导的反义hTERT和野生型PTEN联合转染能明显抑制恶性胶质瘤细胞的生长。 Objective To study inhibitory efficacy of combined gene therapy for malignant ghomas transfected with antisense human telomerase reverse transcriptase (hTERT)/PTEN in vitro and in vivo. Methods To construct two adenovirus recons which contained antisense hTERT and wild-type PTEN respectively with high performance homologous recombination system in bacteria. The two adenovirus recons were transfected into U251 human mahgnant ghoma cells eombinedly or respectively in vitro and in vivo. U251 cell proliferation in vitro was determined by MTT assay and flow cytometry, tumor growth in vivo was measured by the volume of ghoma in nude mice. Telomerase activity was detected by telomerie repeat amplification protocol (TRAP) assay. Expression of hTERT and PTEN protein was detected by Western blotting methods. Reeults After transfection in vitro, the growth of U251 cells was inhibited significantly. The inhibitory effect was time-dependent. The strongest inhibition was observed in combined transfection group, at the 6th day, the survival rate was 37.6%, telomerase activity (only 28.8TPG) was inhibited significantly, hTERT protein expression was inhibited significantly too, which was 0.2106, but PTEN protein expression was increased significantly, which was 0.9630. In vivo, the growth of tumors was also effectively inhibited. Conclusion Growth of malignant glioma cells is effectively inhibited after transfection with combined antisense hTERT and PTEN in vitro and in vivo.
出处 《中华医学遗传学杂志》 CAS CSCD 北大核心 2006年第6期605-609,共5页 Chinese Journal of Medical Genetics
基金 中国博士后科学基金(2003033497) 江苏省自然科学基金创新人材项目(BK2004428)~~
关键词 反义hTERT基因 野生型PTEN基因 联合基因治疗 恶性胶质瘤 antisense hTERT gene wild-type PTEN gene combined gene therapy malignant glioma
  • 相关文献

参考文献15

  • 1Gurrney JG,Kadan-Lottick N.Brain and other central nervous system tumors:rates,trends,and epidemiology.Curr Opin Oncol,2001,13∶160-166.
  • 2尤永平,浦佩玉,彭琼,夏之柏,黄强,王春燕,王广秀.神经上皮肿瘤中端粒酶活性及其调节[J].中华外科杂志,2002,40(2):90-93. 被引量:8
  • 3Takakura M,Kyo S,Kanaya T,et al.Cloning of human telomerase catalytic subunit(hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells.Cancer Res,1999,59∶551-557.
  • 4Kyo S,Inoue M.Complex regulatory mechanisms of telomerase activity in normal and cancer cells:how can we apply them for cancer therapy.Oncogene,2002,21∶688-697.
  • 5Fan X,Aalto Y,Sanko SG,et al.Genetic profile,PTEN mutation and therapeutic role of PTEN in glioblastomas.Int J Oncol,2002,21∶1141-1150.
  • 6Tanaka M,Grossman HB.In vivo gene therapy of human bladder cancer with PTEN suppresses tumor growth,down regulates phosphorylated Akt,and increases sensitivity to doxorubicin.Gene Ther,2003,10∶1636-1642.
  • 7Jacobs AH,Voges J,Kracht LW,et al.Imaging in gene therapy of patients with glioma.J Neurooncol,2003,65∶291-305.
  • 8Grill J,van Beusechem VW,Van-Der-Valk P,et al.Combined targeting of adenoviruses to integrins and epidermal growth factor receptors increases gene transfer into primary glioma cells and spheroids.Clin Cancer Res,2001,7∶641-650.
  • 9Yokoyama Y,Takahashi Y,Shinohara A,et al.The 5′-end of hTERT mRNA is a good target for hammerhead ribozyme to suppress telomerase activity.Biochem Biophys Res Commun,2000,273∶316-321.
  • 10王孝养,张珍祥,徐永健,陈仕新,熊维宁.端粒酶逆转录酶基因反义寡核苷酸抑制肺癌细胞端粒酶活性和诱导细胞凋亡[J].中华内科杂志,2002,41(3):175-178. 被引量:9

二级参考文献13

  • 1C.W.迪芬芭赫 黄培堂译.PCR技术实验指南[M].北京:科学出版社,1999.206-217.
  • 2Feng J;Funk WD;Wang SS.The RNA component of human telomerase[J],1995(5228).
  • 3Kyo S;Kanaya T;Takakura M.Human telomerase reverse transcriptase as a critical determinant of telomerase activity in normal and malignant endometrial tissues[J],1999.
  • 4Takakura M;Kyo S;Kanaya T.Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer[J],1998.
  • 5Kim NM;Piatysrek MA;Prowse KR.Specific association of human telomerase activity with immortal cells and cancer[J],1994.
  • 6HiragaS;Ohnishi T;Tzumoto S.Telomerase activity and alterations in telomere length in human brain tumors[J],1998.
  • 7Shay JW;Bacchetti S.A survey of telomerase activity in human cancer[J],1997.
  • 8Avilion AA;Piatyszek MA;Gupta J.Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues,1996.
  • 9Meyerson M;Counter CM;Eaton EN.hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization[J],1997.
  • 10Andrea GB;Michel O;Maria F.Extension of life-span by introduction of telomerase into normal human cells[J],1998.

共引文献14

同被引文献69

引证文献6

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部